Cargando…
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
BACKGROUND: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how to re‐establish this balance. Here, we investigated whether t...
Autores principales: | Cid‐Díaz, Tania, Leal‐López, Saúl, Fernández‐Barreiro, Fátima, González‐Sánchez, Jessica, Santos‐Zas, Icía, Andrade‐Bulos, Luis J., Rodríguez‐Fuentes, Manuel E., Mosteiro, Carlos S., Mouly, Vincent, Casabiell, Xesús, Relova, Jose Luis, Pazos, Yolanda, Camiña, Jesus P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061369/ https://www.ncbi.nlm.nih.gov/pubmed/33687156 http://dx.doi.org/10.1002/jcsm.12677 |
Ejemplares similares
-
Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid‐induced muscle cell atrophy
por: Cid‐Díaz, Tania, et al.
Publicado: (2017) -
Obestatin controls skeletal muscle fiber-type determination
por: Santos-Zas, Icía, et al.
Publicado: (2017) -
Publisher Correction: Obestatin controls skeletal muscle fiber-type determination
por: Santos-Zas, Icía, et al.
Publicado: (2018) -
Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment
por: González‐Sánchez, Jessica, et al.
Publicado: (2018) -
Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells
por: Sánchez-Temprano, Agustín, et al.
Publicado: (2021)